Clinical Trials Logo

Clinical Trial Summary

The present study aims to compare the effect of adding IV magnesium sulfate versus magnesium sulfate to intrathecal hyperbaric bupivacaine in total abdominal hysterectomy regarding the duration of postoperative analgesia, hemodynamic stability, and complications.


Clinical Trial Description

Abdominal Hysterectomy (AH) is associated with an intense inflammatory response that can result in moderate to severe postoperative pain, sometimes difficult to control. Postoperative pain can cause many complications such as restlessness, increased sympathetic activity, high blood pressure, and tachycardia. Opioids are effective analgesics; however, they produce unwanted side effects, such as respiratory depression, nausea, and vomiting. Nonopioid drugs can decrease opioid usage and dependency. Different adjuvants have been added to local anesthetics to increase the duration of the regional anesthesia, decrease pain-relieving drugs, and delay the onset of postoperative pain. According to numerous reports, Magnesium sulfate has analgesic effects and lowers opioid consumption in many surgeries especially abdominal surgeries. The analgesic properties of magnesium are based on acting as a non-competitive antagonist of N-Methyl-D-Aspartate (NMDA) receptors in central nervous system and regulating the calcium influx into the cell. These properties avoid the central sensitization mechanisms due to the stimulation of peripheral nociceptive nerves In the spinal cord, magnesium sulfate decreases pain transmission by hyperpolarizing spinal interneurons via G-protein-mediated activation of potassium channels and by decreasing the release of the neurotransmitters (substance P and glutamate) from primary afferent terminals. Adequate postoperative pain relief can enhance recovery and increase patient satisfaction. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06367595
Study type Interventional
Source Assiut University
Contact Marwa S Hassanein, Res
Phone 00201159511004
Email marwasalah2525@gmail.com
Status Not yet recruiting
Phase Phase 2
Start date June 2024
Completion date November 2026

See also
  Status Clinical Trial Phase
Completed NCT05644873 - Intravenous Administration of Magnesium Sulfate in Hysterectomy Cases N/A
Completed NCT03443271 - Effect of TAP Block on Stress Hormones Phase 4
Completed NCT05420662 - The Application of Vaginal Manipulator in Abdominal Hysterectomy Operations N/A
Completed NCT01492075 - A Comparison Between Continuous and Intermittent Intraabdominal Analgesia Using Local Anaesthetics Phase 4
Completed NCT04366375 - Pentraxin-3 in Hysterectomy Patients
Completed NCT04724564 - Correlation of Different Time Measurements of the Surgical PLETH Index With Postoperative Pain
Completed NCT03748108 - Bolus Administration of Intravenous Lidocaine at the Time of Abdominal Hysterectomy N/A
Completed NCT03965637 - Intravenous Ascorbic Acid Administration in Hysterectomy Phase 3
Completed NCT05611944 - Irrigation and Suction Trial to Prevent SSI N/A